Furthermore, tumor-restraining CAF may increase antitumor immunity, by secretion of immunomodulatory cytokines such as IL-10, TNF, and IL-6, aiding in recruitment of macrophages and T lymphocytes, thus converting an immune-suppressive into immune-stimulating cancer microenvironment [98]. This evidence concerns the gene IL6 and neoplasm.